DE69637216D1 - Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem - Google Patents

Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem

Info

Publication number
DE69637216D1
DE69637216D1 DE69637216T DE69637216T DE69637216D1 DE 69637216 D1 DE69637216 D1 DE 69637216D1 DE 69637216 T DE69637216 T DE 69637216T DE 69637216 T DE69637216 T DE 69637216T DE 69637216 D1 DE69637216 D1 DE 69637216D1
Authority
DE
Germany
Prior art keywords
immune system
nonembryonal
inibiator
costimulatory
transplanted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69637216T
Other languages
English (en)
Inventor
Collin J Weber
Mary K Hagler
Peter S Linsley
Judith A Kapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Bristol Myers Squibb Co
Original Assignee
Emory University
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University, Bristol Myers Squibb Co filed Critical Emory University
Priority claimed from PCT/US1996/015577 external-priority patent/WO1997011607A1/en
Application granted granted Critical
Publication of DE69637216D1 publication Critical patent/DE69637216D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69637216T 1995-09-27 1996-09-27 Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem Expired - Fee Related DE69637216D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60437595A 1995-09-27 1995-09-27
PCT/US1996/015577 WO1997011607A1 (en) 1995-09-27 1996-09-27 Method of inhibiting immune system destruction of transplanted viable cells

Publications (1)

Publication Number Publication Date
DE69637216D1 true DE69637216D1 (de) 2007-10-04

Family

ID=38284026

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637216T Expired - Fee Related DE69637216D1 (de) 1995-09-27 1996-09-27 Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem

Country Status (3)

Country Link
EP (1) EP0877555B1 (de)
AT (1) ATE370741T1 (de)
DE (1) DE69637216D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140112958A1 (en) 2012-10-24 2014-04-24 Mwm Biomodels Gmbh Pancreatic islets of transgenic LEA29Y animals for treating diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO166836C (no) * 1985-03-14 1991-09-11 Univ California Fremgangsmaate for behandling av et organtransplantat.
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods

Also Published As

Publication number Publication date
EP0877555B1 (de) 2007-08-22
EP0877555A4 (de) 2000-12-20
ATE370741T1 (de) 2007-09-15
EP0877555A1 (de) 1998-11-18

Similar Documents

Publication Publication Date Title
DE69330181D1 (de) Mehrschichtiger vliesstoff, verfahren und vorrichtung zu dessen herstellung, sowie diesen vliesstoff enthaltende absorbierende produkte
DE59607301D1 (de) Verfahren zur Herstellung von photopolymeren Hochdruckplatten
ATE221086T1 (de) Photovernetztes hyaluronsäuregel und verfahren zu dessen herstellung
DE69626961T2 (de) Wegwerfkleidungsstück, verfahren und vorrichtung zu dessen herstellung
DE69801771T2 (de) Durch innenhochdruck geformtes raumfachwerk und verfahren zu dessen herstellung
DE69624719T2 (de) Mehrschichtiger, atmungsfähiger film sowie verfahren zu dessen herstellung
DE68919100D1 (de) Piezoelektrischer Summer und Verfahren zu dessen Herstellung.
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
DE50004150D1 (de) Polymorphe von telmisartan, verfahren zu deren herstellung und deren verwendung zur herstellung eines arzneimittels
DE69606788T2 (de) Verfahren zur Herstellung eines modifiziertes Raney-Katalysators
DE69113386D1 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE59610595D1 (de) OLIGO-p-PHENYLEN-EINHEITEN ENTHALTENDE POLYMERE, VERFAHREN ZU IHRER HERSTELLUNG SOWIE IHRE VERWENDUNG
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
ATE192431T1 (de) Fluorphenylsubstituierte alkenylcarbonsäureguanidine als natriumprotonen- antiporter-inhibitoren, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
DE69624355D1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
ATE338022T1 (de) Substituierte norbornylamino-derivate, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
DE59606907D1 (de) Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
DE69637216D1 (de) Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem
DE69517191D1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE69315868T2 (de) Copolymerlatex, Verfahren zu dessen Herstellung sowie dessen Verwendung
ATE216235T1 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
ATE309981T1 (de) Gallensäure-substituierte phenyl- alkenoylguanidine, verfahren zu ihrer herstellung,ihre verwendung als medikamente oder diagnostika sowie sie enthaltende medikamente
ATE211463T1 (de) 4-fluoralkyl-substituierte benzoylguandine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE19781419T1 (de) Formling sowie Verfahren und Vorrichtung zu dessen Herstellung
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee